This was demonstrated for the angiogenic marker CD93, which has a pathogenic role both in the context of obesity and cardiovascular disease [61], as well as in preeclampsia, emphasizing the relevance of these markers in broader pathological contexts. This evidence concerns the gene CD93 and obesity disorder.